Evidence map›Paper›PMID 19884793›Full record

ArticleCell cycle (Georgetown, Tex.)2009

microRNA cascade in diabetic kidney disease: Big impact initiated by a small RNA.

Mitsuo Kato, Rama Natarajan

Abstract readEditorial
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Aldosterone regulates microRNAs in the cortical collecting duct to alter sodium transport.Journal of the American Society of Nephrology : JASN · 2014
    Article
  4. MicroRNAs in Diabetic Kidney Disease.International journal of endocrinology · 2014
    Review
  5. Micro-RNAs in inflammatory diseases and as a link between inflammation and cancer.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2013
    Review
  6. MicroRNAs and diabetic complications.Journal of cardiovascular translational research · 2012
    Review
  7. Review
  8. Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy.Journal of the American Society of Nephrology : JASN · 2012
    Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mitsuo Kato
Rama Natarajan

Funding

Transforming growth factor beta1, microRNAs, lncRNA and diabetic nephropathyR01DK081705 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI NATARAJAN, RAMA · 2009 to 2023
$6.1M
NIDDK NIH HHS R01 DK081705
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsDiabetic NephropathiesGene Expression RegulationHumansMiceMicroRNAsPTEN PhosphohydrolaseSignal TransductionTransforming Growth Factor betaMicroRNAsPTEN PhosphohydrolaseTransforming Growth Factor beta

Identifiers

PMID19884793
PMCPMC3820839

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.